Hepatic glycosphingolipid deficiency and liver function in mice.
about
Ceramides and glucosylceramides are independent antagonists of insulin signalingCorrection of liver steatosis by a hydrophobic iminosugar modulating glycosphingolipids metabolism.Simplifying complexity: genetically resculpting glycosphingolipid synthesis pathways in mice to reveal function.Lipidomics of glycosphingolipids.The twists and turns of sphingolipid pathway in glucose regulationA world of sphingolipids and glycolipids in the brain--novel functions of simple lipids modified with glucose.My journey into the world of sphingolipids and sphingolipidoses.Compounds of the sphingomyelin-ceramide-glycosphingolipid pathways as secondary messenger molecules: new targets for novel therapies for fatty liver disease and insulin resistance.Developmental vascular remodeling defects and postnatal kidney failure in mice lacking Gpr116 (Adgrf5) and Eltd1 (Adgrl4).Lipidomic analysis of the liver identifies changes of major and minor lipid species in adiponectin deficient mice.β-glycosphingolipids ameliorated non-alcoholic steatohepatitis in the Psammomys obesus model.Glycosphingolipids are essential for intestinal endocytic function.Inhibition of hepatocellular carcinoma growth by blockade of glycosphingolipid synthesis.Diastereomer-specific quantification of bioactive hexosylceramides from bacteria and mammals.Impaired liver regeneration by β-glucosylceramide is associated with decreased fat accumulation.
P2860
Q34384118-8FFB0F73-3C0B-453E-B0C7-9270159E1350Q34440771-6A2B0DED-C835-4857-84F2-38F52DBD5D49Q34577669-9B0D8A5A-420D-4FB9-B6B2-5E44E8EC1937Q37512584-7B4A552E-E275-4C28-B16E-DB9A6567E24CQ37766367-12EA24E9-F101-4B7D-B04B-D14AD4CC2D8EQ38002318-66F150BA-055E-484F-9DE4-9A638300104DQ38066410-E55877C6-0F88-455D-8A0A-28D3ECA357F0Q38833111-8B227F94-0C63-4646-9054-E350FD195CFAQ41383455-E6656B39-B03E-48AC-A02F-B2CE0F6113ECQ41900595-20D94ACC-D511-4FA7-99DA-78470ED6D997Q42066264-C59BD64D-9EE5-4251-9CDE-AB6B83B8C8F3Q42139255-8527A089-D069-47FD-A793-636DF6B97B9EQ47220465-462866D9-34FE-4017-A7F6-AFC2ACA34308Q48326911-38EE5DB5-FD68-4A8E-B345-E5A114B03C71Q51075878-B78ED44B-5DF2-490D-BB29-F1450C2B8401
P2860
Hepatic glycosphingolipid deficiency and liver function in mice.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh-hant
name
Hepatic glycosphingolipid deficiency and liver function in mice.
@en
Hepatic glycosphingolipid deficiency and liver function in mice.
@nl
type
label
Hepatic glycosphingolipid deficiency and liver function in mice.
@en
Hepatic glycosphingolipid deficiency and liver function in mice.
@nl
prefLabel
Hepatic glycosphingolipid deficiency and liver function in mice.
@en
Hepatic glycosphingolipid deficiency and liver function in mice.
@nl
P2093
P2860
P356
P1433
P1476
Hepatic glycosphingolipid deficiency and liver function in mice.
@en
P2093
Carsten Sticht
Hermann-Josef Gröne
Johannes M Aerts
Karen Ghauharali
Richard Jennemann
Roger Sandhoff
Shijun Wang
Sylvia Kaden
Theo J van Berkel
P2860
P304
P356
10.1002/HEP.23545
P407
P577
2010-05-01T00:00:00Z